# Enhanced Genomics Limited

## Details

- **Company number:** [12423696](https://find-and-update.company-information.service.gov.uk/company/12423696)
- **Status:** Active
- **Type:** Private Limited Company
- **Incorporated:** 24 Jan 2020
- **Registered office:** ENHANCED GENOMICS ST JOHN'S INNOVATION CENTRE, COWLEY ROAD, CAMBRIDGE, CB4 0WS
- **Nature of business:** [72110](/sic/72110) Research and experimental development on biotechnology
- **Corporate group:** [GMV Nominees Ltd](/group/4) (48357 companies)


## Previous names

- Enhanc3d Genomics Ltd (until 3 Sep 2025)



## Officers

| Name | Role | Appointed | Resigned |
|---|---|---|---|
| JONES, Hazel Joanne, Dr | director | 7 May 2024 | 4 Feb 2025 |
| MAURICE, Catherine | secretary | 1 Apr 2025 | 1 Jul 2026 |



## Control

| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Dr Mikhail Spivakov | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent, right-to-appoint-and-remove-directors | 24 Jan 2020 | 5 Aug 2020 |
| Dr Stefan Walter Schoenfelder | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent, right-to-appoint-and-remove-directors | 24 Jan 2020 | 5 Aug 2020 |
| Prof Peter John Fraser | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent, right-to-appoint-and-remove-directors | 24 Jan 2020 | 5 Aug 2020 |
| Prof Peter John Fraser | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 8 Dec 2020 | 1 Apr 2021 |
| Bioqube Factory Fund I Commv | ownership-of-shares-25-to-50-percent | 30 Mar 2021 | 2 Sep 2022 |
| Mnl (Parkwalk) Nominees Limited | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 26 Nov 2025 |  |
| Bgf Investment Management Limited | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 28 Aug 2025 |  |



## Accounts

| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Dec 2024 | £3,694,275 | £1,933,315 | 21 |
| 31 Dec 2023 | £7,120,276 | £6,479,614 | 12 |
| 31 Dec 2022 | £9,783,520 | £8,965,975 | 8 |
| 31 Dec 2021 | £965,058 | £855,508 | 7 |



## Owned by

Enhanced Genomics Limited → [BGF Investment Management Limited](/company/10608481) → [BGF Group PLC](/company/10657226) → [Barclays Funds Investments Limited](/company/04002470) → [Barclays Equity Holdings Limited](/company/02569002) → [Barclays Principal Investments Limited](/company/08116604)